Pall Biotech, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs. The unmatched portfolio of traditional and single-use products is backed by custom service support and is both scalable and easily integrated to support processes from R&D through to commercial phases of production, including formulation/filling. As a core driver of the continuous bioprocessing movement, Pall Biotech has remained focused on delivering innovative semi- and fully continuous solutions, with the goal of continuously improving bioprocesses for a safer, healthier future.

  • Area de Negocio
  • Vacunas
  • Terapia génica
  • Terapia celular
  • Servicios de investigación
  • Servicios CRO CMO
  • Productos de la sangre
  • Ingeniería
  • Fabricantes de APIs y productos químicos
  • Consultoría
  • Biología celular y molecular
  • Tipo de Empresa
  • Biotecnología sanitaria
  • Servicios y consultoría para el sector biotech
  • Biotecnología industrial – Fabricantes
Valgrande nº 8, 1º planta
Alcobendas, Madrid 28108, ES
T: 34 91 657 98 10

The comprehensive portfolio of products includes:
•Cartridges and Elements
•Filter Housings
•Membranes and Materials
•Sterile Connectors
•Service and Technical Support
•Sheet Filters and Modules
•Sterilizable Packaging
•Syringe Filters
•Systems, Accessories and Components
Customizable Support Services and Capabilities
The Pall Biotech team delivers industry leading process validation and technical support to customers as a daily standard, with assurance that global regulatory compliance rules are understood, and met (or exceeded). Additionally, the team offers access to customizable support service add-ons that help customers overcome challenges and meet goals more efficiently.
With more than 30 years of established service, the Pall Biotech Scientific and Laboratory Services (SLS) group is an established authority in fluid management. SLS scientists, engineers, and technicians work in state-of-the-art facilities in the Americas, Europe, Australia and Asia to deliver compatibility studies, extractable and leachable studies, particulate validation and more, via:
•SLS Centers of Excellence for state-of the-art analytical biopharma testing services
•SLS Laboratory Centers for advanced laboratory testing, failure analysis and validation services
•SLS Customer Support Centers for small lab(s)/basic testing
Pall Biotech also features Pall Advanced Separation Systems (PASS) facilities across the globe to deliver excellence in bioprocess engineering and project execution, providing customers with invaluable resources that enable:
•Automated operations
•Linear scale-up
•Streamlined processes

Pall Biotech’ comprehensive portfolio of traditional and single-use upstream, downstream and viral filtration technologies is enhanced by a global network of ISO9001 certified manufacturing facilities, and a full range of Scientific and Laboratory Services (SLS), technical process and validation support.

The portfolio has been designed to offer easily integrated, scalable solutions to support the evolving needs of global researchers and manufacturers of:
·Biopharmaceuticals/Large Molecule Drugs
·Cell and Gene Therapies
·Vaccines and Plasma
·Active Pharmaceutical Ingredients (APIs)